Clinical Trial

Trial Protocol ID USOR 23229_TTX-030-003

Trial Description

An open-label multicenter 3-arm randomized Phase 2 study to assess the efficacy and safety of TTX-030 and chemotherapy with or without budigalimab, compared to chemotherapy alone, for the treatment of patients not previously treated for metastatic pancreatic adenocarcinoma

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Mohit Narang, M.D.

Disease Types

Sponsors

  • Trishula Therapeutics, Inc.

ClinicalTrials.gov NCT ID

  • NCT06119217